Sanofi
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
54/100
Moderate Influence
$11.1M
Total Lobby Spend
4
Policy Issues
4
Lobbyists
1
Revolving Door
Sanofi reported $11.1 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Labor
Dept of Agriculture
US Trade Representative
Dept of Housing & Urban Development
Federal Energy Regulatory Commission
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Holland & Knight LLP | HCRGOV | 2 | $458K |
| 2020 Apr-Jun | Holland & Knight LLP | GOVHCRPHA | 3 | $310K |
| 2020 Jul-Sep | Cassidy & Associates LLP | GOVHCRPHA+1 | 4 | $391K |
| 2020 Oct-Dec | Brownstein Hyatt LLP | HCRMED | 2 | $343K |
| 2021 Jan-Mar | K&L Gates LLP | HCR | 3 | $682K |
| 2021 Apr-Jun | Cassidy & Associates LLP | GOVPHAHCR+1 | 4 | $474K |
| 2021 Jul-Sep | Covington & Burling LLP | PHAGOVMED+1 | 4 | $474K |
| 2021 Oct-Dec | BGR Group LLP | HCRGOVMED | 3 | $527K |